FINWIRES · TerminalLIVE
FINWIRES

Methanex Seen Benefiting From Elevated Methanol Pricing Despite Expected Normalization, RBC Says

By

Methanex (MEOH) is expected to benefit from a still-elevated methanol pricing environment even as prices gradually normalize over the medium term, according to updated industry forecasts and ongoing supply-side disruptions, RBC Capital said in a Friday note.

Commodity Market Analytics raised its methanol price outlook through 2028, with the largest upward revisions in 2027 due to supply constraints in the Middle East and logistical disruptions such as the Strait of Hormuz, while prices are still expected to gradually ease from late 2026 but remain above pre-disruption levels, according to the report.

RBC noted that Methanex's near-term reference prices are expected to remain stable across North America, China, and Asia Pacific, with elevated pricing supporting strong free cash flow generation and 2026 prices likely staying well above historical averages, aiding deleveraging efforts.

The analyst said Methanex's earnings are highly sensitive to methanol price changes, which significantly impact adjusted EBITDA, and added that the company has potential capital allocation flexibility, including continued debt reduction and possible share buybacks starting in late 2026.

RBC maintained its sector perform rating on the stock with a price target of $70.

Methanex shares were up 2% in Monday trading.

Price: $60.28, Change: $+1.18, Percent Change: +2.00%

Related Articles

Wire

Ensign Group's Regulatory, Reimbursement Concerns 'Overblown,' Oppenheimer Says

Ensign Group's (ENSG) recent stock price drop presents a buying opportunity, as regulatory and reimbursement concerns are "overblown," Oppenheimer said in a note Monday.With the company maintaining its strong operational performance, it should be able to handle volatility in managed care admissions and referrals, which represent about 14% of patient days and 20% of revenue, Oppenheimer analysts said.Ensign's occupancy percentage has risen to 84.3% but remains below its competitors'. The difference can be partially explained by market-related factors, and presents a long-term upside for the company, the analysts said.Oppenheimer also pointed to Ensign's acquisition pipeline as a driver of growth, noting that the company has added 71 locations since the start of 2025 and continues to see a healthy pipeline of merger and acquisition opportunities.Ensign's strategy of acquiring underperforming assets and unlocking operational upside from those facilities has helped it outperform in the historically challenging skilled nursing facility operating and reimbursement environment, according to the note.Oppenheimer maintained the company's stock rating at outperform, with a price target of $210.Price: $165.20, Change: $-2.46, Percent Change: -1.46%

$ENSG
Wire

Market Chatter: Walmart Limits Staff's Usage of AI Tool After High Demand

Walmart (WMT) is capping its staff's usage of an artificial intelligence agent following a period of high demand, Bloomberg reported Monday, citing people familiar with the matter.The retail giant is now offering a limited amount of "tokens" per worker to use the AI agent, called Code Puppy, which helps employees with spreadsheets and presentations, among other tasks, the people reportedly told Bloomberg. Previously, staff had an unlimited amount of tokens, the report said.Walmart didn't immediately reply to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $113.81, Change: $-1.94, Percent Change: -1.68%

$WMT
Wire

Walmart Limits Staff's Usage of AI Tool After High Demand, Bloomberg Reports

Walmart Limits Staff's Usage of AI Tool After High Demand, Bloomberg Reports

$WMT